SARS-CoV-2 Post-Infection and Sepsis by Saccharomyces cerevisiae: A Fatal Case Report—Focus on Fungal Susceptibility and Potential Virulence Attributes
-
Published:2023-02-02
Issue:2
Volume:8
Page:99
-
ISSN:2414-6366
-
Container-title:Tropical Medicine and Infectious Disease
-
language:en
-
Short-container-title:TropicalMed
Author:
Ramos Lívia1, Mokus Luca1, Frota Heloisa12ORCID, Santos Marcos1, Oliveira Simone1, Oliveira Manoel3, Costa Gisela3, Alves Ana4ORCID, Bernardes-Engemann Andréa5, Orofino-Costa Rosane45, Aor Ana15, Branquinha Marta16ORCID, Santos André126ORCID
Affiliation:
1. Laboratório de Estudos Avançados de Microrganismos Emergentes e Resistentes (LEAMER), Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes (IMPG), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-902, Brazil 2. Programa de Pós-Graduação em Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro 21941-909, Brazil 3. Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21040-900, Brazil 4. Unidade Docente-Assistencial de Dermatologia, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro 20551-030, Brazil 5. Laboratório de Micologia, Hospital Universitário Pedro Ernesto (HUPE), Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro 20551-030, Brazil 6. Rede Micologia RJ—Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Rio de Janeiro 21941-902, Brazil
Abstract
The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for approximately 6.8 million deaths worldwide, threatening more than 753 million individuals. People with severe coronavirus disease-2019 (COVID-19) infection often exhibit an immunosuppression condition, resulting in greater chances of developing co-infections with bacteria and fungi, including opportunistic yeasts belonging to the Saccharomyces and Candida genera. In the present work, we have reported the case of a 75-year-old woman admitted at a Brazilian university hospital with an arterial ulcer in the left foot, which was being prepared for surgical amputation. The patient presented other underlying diseases and presented positive tests for COVID-19 prior to hospitalization. She received antimicrobial treatment, but her general condition worsened quickly, leading to death by septic shock after 4 days of hospitalization. Blood samples collected on the day she died were positive for yeast-like organisms, which were later identified as Saccharomyces cerevisiae by both biochemical and molecular methods. The fungal strain exhibited low minimal inhibitory concentration values for the antifungal agents tested (amphotericin B, 5-flucytosine, caspofungin, fluconazole and voriconazole), and it was able to produce important virulence factors, such as extracellular bioactive molecules (e.g., aspartic peptidase, phospholipase, esterase, phytase, catalase, hemolysin and siderophore) and biofilm. Despite the activity against planktonic cells, the antifungals were not able to impact the mature biofilm parameters (biomass and viability). Additionally, the S. cerevisiae strain caused the death of Tenebrio molitor larvae, depending on the fungal inoculum, and larvae immunosuppression with corticosteroids increased the larvae mortality rate. In conclusion, the present study highlighted the emergence of S. cerevisiae as an opportunistic fungal pathogen in immunosuppressed patients presenting several severe comorbidities, including COVID-19 infection.
Funder
Brazilian Agencies: Conselho Nacional de Desenvolvimento Científico e Tecnológico Fundação de Amparo à Pesquisa no Estado do Rio de Janeiro Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Immunology and Microbiology
Reference37 articles.
1. The role of co-infections and secondary infections in patients with COVID-19;Feldman;Pneumonia,2021 2. Musuuza, J.S., Watson, L., Parmasad, V., Putman-Buehler, N., Christensen, L., and Safdar, N. (2021). Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE, 16. 3. Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products;Querol;Front. Microbiol.,2015 4. Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: In a child in intensive care unit and review of the literature;Soysal;Med. Mycol. Case Rep.,2017 5. Ventoulis, I., Sarmourli, T., Amoiridou, P., Mantzana, P., Exindari, M., Gioula, G., and Vyzantiadis, T.A. (2020). Bloodstream infection by Saccharomyces cerevisiae in two COVID-19 patients after receiving supplementation of Saccharomyces in the ICU. J. Fungi, 6.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|